LONDON, ONTARIO--(Marketwire - January 31, 2008) - Critical Outcome Technologies Inc. (TSX VENTURE: COT), announced today that the Company will present the data package for its lead oncology compound COTI-2 at BioPartnering North America (BPNA) taking place February 3-5, 2008 in Vancouver, BC.
